Vireo Growth (VREOF) Net Margin (2020 - 2026)
Vireo Growth (VREOF) reported Net Margin of 21.19% for Q1 2026, down 4102.0% on a YoY basis from 0.53% in Q1 2025, and up 34.45% sequentially from 32.32% in Q4 2025.
Vireo Growth (VREOF) Net Margin (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Net Margin data on file, last reported at 21.19% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 4102.0% year-over-year to 21.19%; the trailing twelve-month figure through Mar 2026 stood at 14.22% (down 3178.0% YoY), and the FY2025 full-year result was 30.33%, down 4679.0% from the prior year.
- Net Margin advanced to 21.19% in Q1 2026, from 32.32% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 19.84% in Q1 2025 to a low of 113.07% in Q1 2022.
- A 5-year average of 16.95% and a median of 21.19% in 2026 frame the typical range for Net Margin.
- Across the five-year window, Net Margin slumped 5914 bps in 2022 and soared 6870 bps in 2023, its largest moves.
- Tracing VREOF's Net Margin over 5 years: stood at 48.79% in 2022, then soared by 130 bps to 14.77% in 2023, then gained by 14 bps to 16.81% in 2024, then slumped by 292 bps to 32.32% in 2025, then jumped by 34 bps to 21.19% in 2026.
- Business Quant data shows VREOF's Net Margin at 21.19% in Q1 2026, 32.32% in Q4 2025, and 3.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -21.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.19% |
| Dec 31, 2025 | -32.32% |
| Sep 30, 2025 | 3.01% |
| Jun 30, 2025 | 7.64% |
| Mar 31, 2025 | 19.84% |
| Dec 31, 2024 | 16.81% |
| Sep 30, 2024 | 17.47% |
| Jun 30, 2024 | 16.16% |
| Mar 31, 2024 | 15.36% |
| Dec 31, 2023 | 14.77% |
| Sep 30, 2023 | -23.22% |
| Jun 30, 2023 | -36.59% |
| Mar 31, 2023 | -44.37% |
| Dec 31, 2022 | -48.79% |
| Sep 30, 2022 | -50.78% |
| Jun 30, 2022 | -28.94% |
| Mar 31, 2022 | -113.07% |
| Dec 31, 2021 | -103.17% |
| Sep 30, 2021 | -51.16% |
| Jun 30, 2021 | -49.10% |